Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients

N/ACompletedNCT00727883

AstraZeneca190 enrolled

Overview

Retrospective observational trial on reasons for withdraw of Adjuvant Tamoxifen in Breast Cancer patients

Study Type

OBSERVATIONAL

Enrollment

190

Conditions

Breast Cancer

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Breast Ca Patients with surgery and withdraw of adjuvant treatment with Tamoxifen for Tam related AEs * Documented reasons for treatment withdrawal Exclusion Criteria: * enrollment in other studies * treatment withdraw for other causes than Tam related AEs

Outcomes

Primary Outcomes

incidence of withdraw from adjuvant Tamoxifen due to Tam related AEs

Time frame: January 2003-December 2004

Secondary Outcomes

Types of TAM related AE

Time frame: January 2003-December 2004

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.